Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes

Show full item record



Permalink

http://hdl.handle.net/10138/320487

Citation

Tynjälä , A , Forsblom , C , Harjutsalo , V , Groop , P-H & Gordin , D 2020 , ' Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes ' , Diabetes Care , vol. 43 , no. 9 , pp. 2266-2271 . https://doi.org/10.2337/dc20-0078

Title: Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes
Author: Tynjälä, Anniina; Forsblom, Carol; Harjutsalo, Valma; Groop, Per-Henrik; Gordin, Daniel
Contributor: University of Helsinki, Nefrologian yksikkö
University of Helsinki, Research Programs Unit
University of Helsinki, Research Programs Unit
University of Helsinki, HUS Abdominal Center
University of Helsinki, HUS Abdominal Center
Date: 2020-09
Number of pages: 6
Belongs to series: Diabetes Care
ISSN: 0149-5992
URI: http://hdl.handle.net/10138/320487
Abstract: OBJECTIVE Type 1 diabetes is accompanied by a significant burden of cardiovascular disease (CVD), which is poorly explained by traditional risk factors. We therefore aimed to explore whether arterial stiffness estimated by the augmentation index (AIx) predicts mortality in individuals with type 1 diabetes. RESEARCH DESIGN AND METHODS After baseline examination comprising pulse wave analysis by applanation tonometry alongside assessment of traditional cardiovascular risk factors, 906 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy (FinnDiane) Study were followed up for a median of 8.2 years (interquartile range 5.7-9.7). Associations between baseline hemodynamics, including AIx, and all-cause mortality as well as a composite of cardiovascular and/or diabetes-related mortality were investigated using multivariable Cox regression models. RESULTS The 67 individuals who died during follow-up had higher baseline AIx (median 28% [interquartile range 21-33] vs. 19% [9-27];P<0.001) compared with those alive. This association was independent of conventional risk factors (age, sex, BMI, HbA(1c), estimated glomerular filtration rate [eGFR], and previous CVD event) in Cox regression analysis (standardized hazard ratio 1.71 [95% CI 1.10-2.65];P= 0.017) and sustained in a subanalysis of individuals with chronic kidney disease. Similarly, higher AIx was associated with the composite secondary end point of cardiovascular and diabetes-related death (N= 53) after adjustments for sex, BMI, eGFR, previous CVD event, and height (standardized hazard ratio 2.30 [1.38-3.83];P= 0.001). CONCLUSIONS AIx predicts all-cause mortality as well as a composite cardiovascular and/or diabetes-related cause of death in individuals with type 1 diabetes, independent of established cardiovascular risk factors.
Subject: PULSE-WAVE VELOCITY
AUGMENTATION INDEX
CARDIOVASCULAR-DISEASE
GLYCEMIC CONTROL
BLOOD-PRESSURE
ASSOCIATION
DYSFUNCTION
3121 Internal medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Tynj_l_et_al._Revised_Main_Document_AAM.pdf 870.3Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record